- Home
- QDEL vs FBIOP Comparison
QDEL vs FBIOP Comparison
Compare QDEL & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QDEL
- FBIOP
- Stock Information
- Founded
- QDEL 1979
- FBIOP N/A
- Country
- QDEL United States
- FBIOP United States
- Employees
- QDEL N/A
- FBIOP 186
- Industry
- QDEL Medical Specialities
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- QDEL Health Care
- FBIOP Health Care
- Exchange
- QDEL Nasdaq
- FBIOP Nasdaq
- Market Cap
- QDEL N/A
- FBIOP N/A
- IPO Year
- QDEL N/A
- FBIOP N/A
- Fundamental
- Price
- QDEL $38.92
- FBIOP $5.08
- Analyst Decision
- QDEL Buy
- FBIOP
- Analyst Count
- QDEL 7
- FBIOP 0
- Target Price
- QDEL $58.83
- FBIOP N/A
- AVG Volume (30 Days)
- QDEL 616.3K
- FBIOP N/A
- Earning Date
- QDEL 11-07-2024
- FBIOP N/A
- Dividend Yield
- QDEL N/A
- FBIOP N/A
- EPS Growth
- QDEL N/A
- FBIOP N/A
- EPS
- QDEL N/A
- FBIOP N/A
- Revenue
- QDEL $2,817,700,000.00
- FBIOP N/A
- Revenue This Year
- QDEL N/A
- FBIOP N/A
- Revenue Next Year
- QDEL $0.80
- FBIOP N/A
- P/E Ratio
- QDEL N/A
- FBIOP N/A
- Revenue Growth
- QDEL N/A
- FBIOP N/A
- 52 Week Low
- QDEL $29.74
- FBIOP N/A
- 52 Week High
- QDEL $75.86
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- QDEL 43.50
- FBIOP 49.96
- Support Level
- QDEL $38.71
- FBIOP $5.01
- Resistance Level
- QDEL $46.00
- FBIOP $5.86
- Average True Range (ATR)
- QDEL 1.58
- FBIOP 0.51
- MACD
- QDEL 0.23
- FBIOP -0.03
- Stochastic Oscillator
- QDEL 11.28
- FBIOP 28.99
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.